141 related articles for article (PubMed ID: 11257424)
1. Determination of 14-3-3 protein levels in cerebrospinal fluid from Creutzfeldt-Jakob patients by a highly sensitive capture assay.
Peoc'h K; Schröder HC; Laplanche J; Ramljak S; Müller WE
Neurosci Lett; 2001 Apr; 301(3):167-70. PubMed ID: 11257424
[TBL] [Abstract][Full Text] [Related]
2. A novel binding assay for detection of 14-3-3 protein in cerebrospinal fluid from Creutzfeldt-Jakob patients.
Leuck J; Peoch K; Laplanche JL; Grabar E; Müller WE; Schröder HC
Cell Mol Biol (Noisy-le-grand); 2000 Nov; 46(7):1291-6. PubMed ID: 11075958
[TBL] [Abstract][Full Text] [Related]
3. An enzyme-linked immunosorbent assay to quantify 14-3-3 proteins in the cerebrospinal fluid of suspected Creutzfeldt-Jakob disease patients.
Kenney K; Brechtel C; Takahashi H; Kurohara K; Anderson P; Gibbs CJ
Ann Neurol; 2000 Sep; 48(3):395-8. PubMed ID: 10976650
[TBL] [Abstract][Full Text] [Related]
4. Challenging the clinical utility of the 14-3-3 protein for the diagnosis of sporadic Creutzfeldt-Jakob disease.
Geschwind MD; Martindale J; Miller D; DeArmond SJ; Uyehara-Lock J; Gaskin D; Kramer JH; Barbaro NM; Miller BL
Arch Neurol; 2003 Jun; 60(6):813-6. PubMed ID: 12810484
[TBL] [Abstract][Full Text] [Related]
5. Use of 14-3-3 in the diagnosis of Creutzfeldt-Jakob disease.
Green AJ
Biochem Soc Trans; 2002 Aug; 30(4):382-6. PubMed ID: 12196099
[TBL] [Abstract][Full Text] [Related]
6. Sporadic Creutzfeldt-Jakob disease diagnostic accuracy is improved by a new CSF ELISA 14-3-3γ assay.
Leitão MJ; Baldeiras I; Almeida MR; Ribeiro MH; Santos AC; Ribeiro M; Tomás J; Rocha S; Santana I; Oliveira CR
Neuroscience; 2016 May; 322():398-407. PubMed ID: 26940479
[TBL] [Abstract][Full Text] [Related]
7. Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt-Jakob disease.
Otto M; Wiltfang J; Cepek L; Neumann M; Mollenhauer B; Steinacker P; Ciesielczyk B; Schulz-Schaeffer W; Kretzschmar HA; Poser S
Neurology; 2002 Jan; 58(2):192-7. PubMed ID: 11805244
[TBL] [Abstract][Full Text] [Related]
8. [Clinical algorithm for cerebrospinal fluid test of 14-3-3 protein in diagnosis of Creutzfeldt-Jacob disease].
Lemstra AW; van Meegen M; Baas F; van Gool WA
Ned Tijdschr Geneeskd; 2001 Jul; 145(30):1467-71. PubMed ID: 11503317
[TBL] [Abstract][Full Text] [Related]
9. Increased detection of 14-3-3 protein in cerebrospinal fluid in Sporadic Creutzfeldt-Jakob Disease during the disease course.
Giraud P; Biacabe AG; Chazot G; Later R; Joyeux O; Moene Y; Perret-Liaudet A
Eur Neurol; 2002; 48(4):218-21. PubMed ID: 12422071
[TBL] [Abstract][Full Text] [Related]
10. 14-3-3 in the cerebrospinal fluid of patients with variant and sporadic Creutzfeldt-Jakob disease measured using capture assay able to detect low levels of 14-3-3 protein.
Green AJ; Ramljak S; Müller WE; Knight RS; Schröder HC
Neurosci Lett; 2002 May; 324(1):57-60. PubMed ID: 11983294
[TBL] [Abstract][Full Text] [Related]
11. Quantitation of 14-3-3 and neuron-specific enolase proteins in CSF in Creutzfeldt-Jakob disease.
Aksamit AJ; Preissner CM; Homburger HA
Neurology; 2001 Aug; 57(4):728-30. PubMed ID: 11524493
[TBL] [Abstract][Full Text] [Related]
12. Use of 14-3-3 and other brain-specific proteins in CSF in the diagnosis of variant Creutzfeldt-Jakob disease.
Green AJ; Thompson EJ; Stewart GE; Zeidler M; McKenzie JM; MacLeod MA; Ironside JW; Will RG; Knight RS
J Neurol Neurosurg Psychiatry; 2001 Jun; 70(6):744-8. PubMed ID: 11385008
[TBL] [Abstract][Full Text] [Related]
13. High sensitivity of an ELISA kit for detection of the gamma-isoform of 14-3-3 proteins: usefulness in laboratory diagnosis of human prion disease.
Matsui Y; Satoh K; Miyazaki T; Shirabe S; Atarashi R; Mutsukura K; Satoh A; Kataoka Y; Nishida N
BMC Neurol; 2011 Oct; 11():120. PubMed ID: 21970675
[TBL] [Abstract][Full Text] [Related]
14. 14-3-3 Protein isoforms and atypical patterns of the 14-3-3 assay in the diagnosis of Creutzfeldt-Jakob disease.
Sánchez-Valle R; Saiz A; Graus F
Neurosci Lett; 2002 Mar; 320(1-2):69-72. PubMed ID: 11849766
[TBL] [Abstract][Full Text] [Related]
15. Misleading results with the 14-3-3 assay for the diagnosis of Creutzfeldt-Jakob disease.
Chapman T; McKeel DW; Morris JC
Neurology; 2000 Nov; 55(9):1396-7. PubMed ID: 11087791
[TBL] [Abstract][Full Text] [Related]
16. Autopsy-proven Creutzfeldt-Jakob disease in a patient with a negative 14-3-3 assay and nonspecific EEG and MRI.
Donahue JE; Hanna PA; Hariharan S
Neurol Sci; 2004 Feb; 24(6):411-3. PubMed ID: 14767688
[TBL] [Abstract][Full Text] [Related]
17. [Cerebrospinal fluid diagnosis of Creutzfeldt-Jakob disease].
Bernheimer H; Gatterbauer B; Radbauer C; Budka H
Wien Med Wochenschr; 1998; 148(4):96-100. PubMed ID: 9611349
[TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal fluid brain-derived proteins in the diagnosis of Alzheimer's disease and Creutzfeldt-Jakob disease.
Green AJ
Neuropathol Appl Neurobiol; 2002 Dec; 28(6):427-40. PubMed ID: 12445159
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal Fluid Biomarkers in the Diagnosis of Creutzfeldt-Jakob Disease in Slovak Patients: over 10-Year Period Review.
Koscova S; Zakova Slivarichova D; Tomeckova I; Melicherova K; Stelzer M; Janakova A; Kosorinova D; Belay G; Mitrova E
Mol Neurobiol; 2017 Oct; 54(8):5919-5927. PubMed ID: 27665282
[TBL] [Abstract][Full Text] [Related]
20. A prospective study of CSF markers in 250 patients with possible Creutzfeldt-Jakob disease.
Van Everbroeck B; Quoilin S; Boons J; Martin JJ; Cras P
J Neurol Neurosurg Psychiatry; 2003 Sep; 74(9):1210-4. PubMed ID: 12933920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
